Postoperative pain.
Conditions
Interventions
Intervention 1: Control group: 150 miligram of rupivacaein 0.5 % Astrazeneca france company with 1 mg / kg dexmedetomidine exire iran company to 31 cc and injection to epidural space. Intervention
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patient with ASA class 1,2 Age between 20 to 80
Exclusion criteria
Exclusion criteria: Cardiac disease patient Hematologic disease Skelletal deformity Infection of epidural site Obesity with BMI over 30 History of allergy to drugs that use Addiction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative analgesia with Visual analogue scale score(vas score). Timepoint: 1,2,4,6,12,24 houre after operation. Method of measurement: Visual analogue scale score (vas score). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedeh Fatemeh Hosseininejad
Ahvaz University of Medical Sciences
Outcome results
None listed